The Abbott Laboratories announced on Friday that the price of the AIDS drug, Kaltera, was decreased for the government programs, which will help in reduction of the government’s spending on programs.

The AIDS Healthcare Foundation said that almost 7,700 patients are still on the waiting list for the AIDS and HIV drug assistance program.

The government is making plans for the low-income Americans with HIV infection. Illinois has shortened the eligibility criteria for the enrollment of the patients with HIV and AIDS in assistance programs.

After the cuts in the eligibility criteria, many applicants have enrolled in the AIDS drug assistance programs. Many people have lost their jobs and they cannot pay for the treatment of their disease and hence the government has made such plans for their assistance.

Initially, the health department of Illinois will limit the assistance program to the new applicants, whose income is below 300%, which is $32,670. However, the current qualification for the assistance program is 500%, which is $54,450.

Meanwhile, the Chairman and Chief Executive of the Abbott, Miles White, said that the some of the companies have raised the prices of the drugs for AIDS from 5% to 6%.